FDA Inspection 1204403 — UChicago Medicine AdventHealth La Grange
The FDA completed an inspection of UChicago Medicine AdventHealth La Grange on March 30, 2023 in La Grange, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 30, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- La Grange, IL (United States)